Home Healthcare Healthcare Services Drug Discovery Service Market

Drug Discovery Service Market Size, Share & Trends Analysis Report By Type (Pharmacokinetics, Drug Metabolism, Biology Services, Medicinal Chemistry, Others), By Process (Target Validation, Target Selection, Hit-To-Lead Identification, Candidate Validation, Lead Optimization, Others), By Drug Type (Biologics, Small Molecules), By Therapeutic Area (Neurology, Diabetes, Oncology, Respiratory Diseases, Cardiovascular Diseases, Others), By End-User (Hospital & Clinics, Pharmaceutical Companies, Biotechnology Companies, Research Institute) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Drug Discovery Service Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Pharmacokinetics
    2. Drug Metabolism
    3. Biology Services
    4. Medicinal Chemistry
    5. Others
  2. Drug Discovery Service Market, By Process 2022-2034 (USD MILLION/ Units)
    1. Target Validation
    2. Target Selection
    3. Hit-To-Lead Identification
    4. Candidate Validation
    5. Lead Optimization
    6. Others
  3. Drug Discovery Service Market, By Drug Type 2022-2034 (USD MILLION/ Units)
    1. Biologics
    2. Small Molecules
  4. Drug Discovery Service Market, By Therapeutic Area 2022-2034 (USD MILLION/ Units)
    1. Neurology
    2. Diabetes
    3. Oncology
    4. Respiratory Diseases
    5. Cardiovascular Diseases
    6. Others
  5. Drug Discovery Service Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospital & Clinics
    2. Pharmaceutical Companies
    3. Biotechnology Companies
    4. Research Institute
  6. Regional Drug Discovery Service Market
    1. North America
      1. North America Drug Discovery Service Market By Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
      2. North America Drug Discovery Service Market By Process 2022-2034 (USD MILLION/ Units)
        1. Target Validation
        2. Target Selection
        3. Hit-To-Lead Identification
        4. Candidate Validation
        5. Lead Optimization
        6. Others
      3. North America Drug Discovery Service Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Biologics
        2. Small Molecules
      4. North America Drug Discovery Service Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Neurology
        2. Diabetes
        3. Oncology
        4. Respiratory Diseases
        5. Cardiovascular Diseases
        6. Others
      5. North America Drug Discovery Service Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital & Clinics
        2. Pharmaceutical Companies
        3. Biotechnology Companies
        4. Research Institute
      6. U.S.
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      7. Canada
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
    2. Europe
      1. Europe Drug Discovery Service Market By Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
      2. Europe Drug Discovery Service Market By Process 2022-2034 (USD MILLION/ Units)
        1. Target Validation
        2. Target Selection
        3. Hit-To-Lead Identification
        4. Candidate Validation
        5. Lead Optimization
        6. Others
      3. Europe Drug Discovery Service Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Biologics
        2. Small Molecules
      4. Europe Drug Discovery Service Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Neurology
        2. Diabetes
        3. Oncology
        4. Respiratory Diseases
        5. Cardiovascular Diseases
        6. Others
      5. Europe Drug Discovery Service Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital & Clinics
        2. Pharmaceutical Companies
        3. Biotechnology Companies
        4. Research Institute
      6. U.K.
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      7. Germany
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      8. France
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      9. Spain
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      10. Italy
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      11. Russia
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      12. Nordic
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      13. Benelux
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      14. Rest of Europe
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
    3. APAC
      1. APAC Drug Discovery Service Market By Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
      2. APAC Drug Discovery Service Market By Process 2022-2034 (USD MILLION/ Units)
        1. Target Validation
        2. Target Selection
        3. Hit-To-Lead Identification
        4. Candidate Validation
        5. Lead Optimization
        6. Others
      3. APAC Drug Discovery Service Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Biologics
        2. Small Molecules
      4. APAC Drug Discovery Service Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Neurology
        2. Diabetes
        3. Oncology
        4. Respiratory Diseases
        5. Cardiovascular Diseases
        6. Others
      5. APAC Drug Discovery Service Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital & Clinics
        2. Pharmaceutical Companies
        3. Biotechnology Companies
        4. Research Institute
      6. China
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      7. Korea
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      8. Japan
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      9. India
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      10. Australia
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      11. Taiwan
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      12. South East Asia
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      13. Rest of Asia-Pacific
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
    4. Middle East and Africa
      1. Middle East and Africa Drug Discovery Service Market By Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
      2. Middle East and Africa Drug Discovery Service Market By Process 2022-2034 (USD MILLION/ Units)
        1. Target Validation
        2. Target Selection
        3. Hit-To-Lead Identification
        4. Candidate Validation
        5. Lead Optimization
        6. Others
      3. Middle East and Africa Drug Discovery Service Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Biologics
        2. Small Molecules
      4. Middle East and Africa Drug Discovery Service Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Neurology
        2. Diabetes
        3. Oncology
        4. Respiratory Diseases
        5. Cardiovascular Diseases
        6. Others
      5. Middle East and Africa Drug Discovery Service Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital & Clinics
        2. Pharmaceutical Companies
        3. Biotechnology Companies
        4. Research Institute
      6. UAE
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      7. Turkey
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      8. Saudi Arabia
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      9. South Africa
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      10. Egypt
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      11. Nigeria
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      12. Rest of MEA
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
    5. LATAM
      1. LATAM Drug Discovery Service Market By Type 2022-2034 (USD MILLION/ Units)
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
      2. LATAM Drug Discovery Service Market By Process 2022-2034 (USD MILLION/ Units)
        1. Target Validation
        2. Target Selection
        3. Hit-To-Lead Identification
        4. Candidate Validation
        5. Lead Optimization
        6. Others
      3. LATAM Drug Discovery Service Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Biologics
        2. Small Molecules
      4. LATAM Drug Discovery Service Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Neurology
        2. Diabetes
        3. Oncology
        4. Respiratory Diseases
        5. Cardiovascular Diseases
        6. Others
      5. LATAM Drug Discovery Service Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital & Clinics
        2. Pharmaceutical Companies
        3. Biotechnology Companies
        4. Research Institute
      6. Brazil
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      7. Mexico
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      8. Argentina
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      9. Chile
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      10. Colombia
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
      11. Rest of LATAM
        1. Pharmacokinetics
        2. Drug Metabolism
        3. Biology Services
        4. Medicinal Chemistry
        5. Others
        6. Target Validation
        7. Target Selection
        8. Hit-To-Lead Identification
        9. Candidate Validation
        10. Lead Optimization
        11. Others
        12. Biologics
        13. Small Molecules
        14. Neurology
        15. Diabetes
        16. Oncology
        17. Respiratory Diseases
        18. Cardiovascular Diseases
        19. Others
        20. Hospital & Clinics
        21. Pharmaceutical Companies
        22. Biotechnology Companies
        23. Research Institute
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.